Celldex Therapeutics Inc (CLDX)
42.16
-0.40
(-0.94%)
USD |
NASDAQ |
May 06, 11:55
Celldex Therapeutics Revenue (Quarterly): 4.131M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.131M |
| September 30, 2023 | 1.517M |
| June 30, 2023 | 0.268M |
| March 31, 2023 | 0.967M |
| December 31, 2022 | 1.613M |
| September 30, 2022 | 0.407M |
| June 30, 2022 | 0.163M |
| March 31, 2022 | 0.174M |
| December 31, 2021 | 0.334M |
| September 30, 2021 | 0.153M |
| June 30, 2021 | 3.48M |
| March 31, 2021 | 0.685M |
| December 31, 2020 | 3.785M |
| September 30, 2020 | 0.668M |
| June 30, 2020 | 0.236M |
| March 31, 2020 | 2.728M |
| December 31, 2019 | 0.887M |
| September 30, 2019 | 0.546M |
| June 30, 2019 | 0.715M |
| March 31, 2019 | 1.425M |
| December 31, 2018 | 1.764M |
| September 30, 2018 | 0.941M |
| June 30, 2018 | 2.763M |
| March 31, 2018 | 4.068M |
| December 31, 2017 | 3.456M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.924M |
| June 30, 2017 | 3.829M |
| March 31, 2017 | 1.534M |
| December 31, 2016 | 1.873M |
| September 30, 2016 | 2.22M |
| June 30, 2016 | 1.389M |
| March 31, 2016 | 1.303M |
| December 31, 2015 | 1.791M |
| September 30, 2015 | 1.026M |
| June 30, 2015 | 2.178M |
| March 31, 2015 | 0.486M |
| December 31, 2014 | 1.477M |
| September 30, 2014 | 1.101M |
| June 30, 2014 | 0.592M |
| March 31, 2014 | 0.416M |
| December 31, 2013 | 0.62M |
| September 30, 2013 | 0.98M |
| June 30, 2013 | 0.097M |
| March 31, 2013 | 2.414M |
| December 31, 2012 | 3.647M |
| September 30, 2012 | 3.113M |
| June 30, 2012 | 2.009M |
| March 31, 2012 | 2.433M |
| December 31, 2011 | 2.434M |
| September 30, 2011 | 2.363M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.153M
Minimum
Sep 2021
4.131M
Maximum
Dec 2023
1.235M
Average
0.685M
Median
Mar 2021
Revenue (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | 2.406M |
| Perspective Therapeutics Inc | -5.239M |
| Electromed Inc | 13.69M |
| Xtant Medical Holdings Inc | 28.11M |
| Asensus Surgical Inc | 5.431M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.31M |
| Total Expenses (Quarterly) | 39.26M |
| EPS Diluted (Quarterly) | -0.84 |
| Enterprise Value | 1.956B |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -6.93% |
| Normalized Earnings Yield | -6.995 |